Dr. Robert Deuson is an adjunct fellow specializing in health economics.
Deuson has worked in academia, public health prevention, pharmaceuticals and biotechnology. He was director of global health economics and outcomes research at Covance. Prior to that, he was director of global health economics at Amgen (2005-2012) and associate director for outcomes research at Merck & Co. (2000-2005). At both Amgen and Merck, he managed the entire process of bringing innovative new medicines to market, including reimbursement issues, in the areas of oncology and hematology.
Prior to working at Merck, Deuson was a senior service fellow health economist and preventive medicine and public health fellow at the Centers for Disease Control and Prevention (1996-2000), where he worked in vaccines for the National Immunization Program. At the Canadian International Development Agency (1992-1995), he was science advisor and team leader for the CIRES Project in Abidjan, Ivory Coast, and developed a pioneering M.S. program in agricultural and health economics to train new cadres for public service as well as business. Deuson was also involved in three other development projects in Africa with the United States Agency for International Development (USAID), and he was an assistant professor in agricultural economics at Purdue University (1984-1990).
Deuson received a Ph.D. from the University of Minnesota in agricultural and applied economics, an M.S. in agricultural economics from New Mexico State University and a B.S. in economics from California State Polytechnic University, Pomona. More recently, he obtained an M.S. in health systems from the Georgia Institute of Technology's School of Industrial and Systems Engineering.